X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Biocon Ltd with Lupin Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON LTD vs LUPIN LTD - Comparison Results

BIOCON LTD    Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

LUPIN LTD 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON LTD LUPIN LTD BIOCON LTD/
LUPIN LTD
 
P/E (TTM) x 36.7 16.9 217.3% View Chart
P/BV x 4.9 3.9 124.0% View Chart
Dividend Yield % 1.5 0.8 193.7%  

Financials

 BIOCON LTD   LUPIN LTD
EQUITY SHARE DATA
    BIOCON LTD
Mar-16
LUPIN LTD
Mar-16
BIOCON LTD/
LUPIN LTD
5-Yr Chart
Click to enlarge
High Rs4962,127 23.3%   
Low Rs3971,294 30.6%   
Sales per share (Unadj.) Rs174.3304.1 57.3%  
Earnings per share (Unadj.) Rs44.850.4 88.9%  
Cash flow per share (Unadj.) Rs56.960.7 93.8%  
Dividends per share (Unadj.) Rs5.007.50 66.7%  
Dividend yield (eoy) %1.10.4 255.6%  
Book value per share (Unadj.) Rs202.8243.8 83.2%  
Shares outstanding (eoy) m200.00450.58 44.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.65.6 45.5%   
Avg P/E ratio x10.033.9 29.3%  
P/CF ratio (eoy) x7.828.2 27.8%  
Price / Book Value ratio x2.27.0 31.4%  
Dividend payout %11.214.9 75.0%   
Avg Mkt Cap Rs m89,220770,740 11.6%   
No. of employees `0004.416.4 27.0%   
Total wages/salary Rs m6,36321,077 30.2%   
Avg. sales/employee Rs Th7,894.58,379.6 94.2%   
Avg. wages/employee Rs Th1,441.21,289.0 111.8%   
Avg. net profit/employee Rs Th2,029.71,388.7 146.2%   
INCOME DATA
Net Sales Rs m34,854137,016 25.4%  
Other income Rs m8451,877 45.0%   
Total revenues Rs m35,699138,893 25.7%   
Gross profit Rs m8,20037,535 21.8%  
Depreciation Rs m2,4234,635 52.3%   
Interest Rs m102446 22.9%   
Profit before tax Rs m6,52034,330 19.0%   
Minority Interest Rs m-744-88 849.3%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m5,7540-   
Tax Rs m2,56911,536 22.3%   
Profit after tax Rs m8,96122,707 39.5%  
Gross profit margin %23.527.4 85.9%  
Effective tax rate %39.433.6 117.3%   
Net profit margin %25.716.6 155.1%  
BALANCE SHEET DATA
Current assets Rs m39,93297,790 40.8%   
Current liabilities Rs m16,27653,872 30.2%   
Net working cap to sales %67.932.1 211.7%  
Current ratio x2.51.8 135.2%  
Inventory Days Days5485 63.2%  
Debtors Days Days86121 71.1%  
Net fixed assets Rs m39,10186,379 45.3%   
Share capital Rs m1,000901 111.0%   
"Free" reserves Rs m38,591105,735 36.5%   
Net worth Rs m40,556109,844 36.9%   
Long term debt Rs m20,72453,739 38.6%   
Total assets Rs m84,816224,378 37.8%  
Interest coverage x64.977.9 83.3%   
Debt to equity ratio x0.50.5 104.4%  
Sales to assets ratio x0.40.6 67.3%   
Return on assets %10.710.3 103.6%  
Return on equity %22.120.7 106.9%  
Return on capital %19.021.2 89.5%  
Exports to sales %30.749.1 62.7%   
Imports to sales %20.47.4 273.8%   
Exports (fob) Rs m10,71767,244 15.9%   
Imports (cif) Rs m7,10510,199 69.7%   
Fx inflow Rs m11,78971,405 16.5%   
Fx outflow Rs m8,39317,807 47.1%   
Net fx Rs m3,39653,598 6.3%   
CASH FLOW
From Operations Rs m5,264-3,690 -142.7%  
From Investments Rs m-9,540-69,434 13.7%  
From Financial Activity Rs m10,86758,126 18.7%  
Net Cashflow Rs m6,591-14,998 -43.9%  

Share Holding

Indian Promoters % 40.4 46.6 86.7%  
Foreign collaborators % 20.6 0.2 10,300.0%  
Indian inst/Mut Fund % 8.4 11.3 74.3%  
FIIs % 10.7 31.9 33.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 10.1 197.0%  
Shareholders   109,995 98,259 111.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON LTD With:   ELDER PHARMA  FDC LTD.  SHASUN PHARMA  STRIDES SHASUN LTD  TTK HEALTHCARE  

Compare BIOCON LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Strong; Consumer Durables Stocks Drag(01:30 pm)

After opening the day in green, share markets in India have continued the momentum and are trading above the dotted line. Except stocks in the consumer durables sector.

Related Views on News

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Biocon: High Other Income And Licensing Income Drive Growth (Quarterly Results Update - Detailed)

Nov 7, 2016

Biocon has announced its 2QFY17. The company has reported 19.8% YoY growth in net sales and profits of Rs 1.5 bn for the quarter. Here is our analysis of the results.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON LTD SHARE PRICE


Aug 23, 2017 03:36 PM

TRACK BIOCON LTD

  • Track your investment in BIOCON LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

BIOCON LTD - JUBILANT LIFE SCIENCES COMPARISON

COMPARE BIOCON LTD WITH

MARKET STATS